Global Infertility Drugs Market Report 2022: Factors Increasing Male and Female Infertility Driving Growth – ResearchAndMarkets.com

DUBLIN-(BUSINESS WIRE)–The report Global Infertility Drugs Market Size, Share and Industry Trend Analysis by End User, by Distribution Channel (Hospital Pharmacy, Specialty Pharmacy & Retail Pharmacy & Online Pharmacy), by Class Medicines, by Regional Outlook and Forecast, 2022 – 2028″ report added ResearchAndMarkets.com supply.

The global infertility drugs market size is expected to reach USD 4.8 billion by 2028, growing at a market growth of 6.2 % CAGR during the forecast period.

Market growth factors

Factors increasing the incidence of male and female infertility

The increasing prevalence of infertility or difficulty in conceiving a baby worldwide is what is fueling the infertility drug market. Infertility can be caused by a number of conditions that affect both men and women, including diabetes, cystic fibrosis, testicular failure, hormonal imbalance, menopausal disorders, urinary tract infections, pelvic inflammatory disease (PID), endometriosis, cysts of the ovaries, among others. Smoking, anabolic steroid use, stress, obesity, and other poor lifestyle choices are to blame for increasing the incidence of these problems, which also contributes to the need for fertility drugs.

Increasing research and development for better treatments

Due to increasing research and development for more effective treatments to induce conception and birth of live babies, the market for infertility drugs is expected to expand significantly. For example, a group of researchers at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health (NIH) found in 2014 that women treated with letrozole had higher rates of ovulation and live births than women treated with the standard drug clomiphene.

Outlook for end user

On the basis of end user, the infertility drugs market is segmented into male and female. The women segment was the market leader with the largest market revenue share in 2021. This dominance may be related to the widespread availability of female infertility drugs. In the United States, 11 percent of women and 9 percent of men of reproductive age have infertility, according to the U.S. Department of Health and Human Services.

Outlook for distribution channel

On the basis of distribution channel, the infertility drugs market is segmented into hospital pharmacy, specialty pharmacy and retail pharmacy, and online pharmacy. Online pharmacy generated the significant revenue share in the market in 2021. The emergence of online clinical chains that provide patients with scheduled drug supply and promote patient discretion due to the social stigma associated with the disease can be attributed to the rise of the segment.

Drug class prediction

On the basis of drug class, the infertility drug market is classified into gonadotropins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), dopamine agonists, and others. The gonadotropin segment accounts for the highest revenue share in the market in 2021. This can be attributed to the high-cost nature of the goods and the greater effect of efficacy on the growing consumption. The gonadotropins Gonal-F, Follitism, Menopur and Bravelle are among the most commonly prescribed to treat infertility in patients.

Scope of the study

By end user

By distribution channel

  • Hospital pharmacy

  • Specialty Pharmacy and Retail Pharmacy

  • Online pharmacy

By drug class

  • Gonadotropins

  • Aromatase inhibitors

  • Selective Estrogen Receptor Modulators (SERMs)

  • Dopamine agonists

  • others

Key players in the market

List of companies profiled in the report:

  • Abbott Laboratories

  • Bayer AG

  • Novartis AG

  • Merck & Co., Inc.

  • Pfizer, Inc.

  • Teva Pharmaceuticals Industries Ltd.

  • Sanofi SA

  • Ferring Holdings SA

  • Organon & Co.

  • Mankind Pharma Ltd.

Main topics covered:

Chapter 1. Market scope and methodology

Chapter 2. Market overview

Chapter 3. Global Infertility Drugs Market by End User

Chapter 4. Global Infertility Drugs Market by Distribution Channel

Chapter 5. Global Infertility Drugs Market by Drug Class

Chapter 6. Global Infertility Drugs Market by Region

Chapter 7. Company Profiles

For more information on this report, visit https://www.researchandmarkets.com/r/j24u5p

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We bring you the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.

Leave a Comment

Your email address will not be published. Required fields are marked *